The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $200.59 in the prior trading day, Biogen Inc (NASDAQ: BIIB) closed at $201.63, up 0.52%. In other words, the price has increased by $0.52 from its previous closing price. On the day, 0.69 million shares were traded. BIIB stock price reached its highest trading level at $203.51 during the session, while it also had its lowest trading level at $200.52.
Ratios:
Our goal is to gain a better understanding of BIIB by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.48 and its Current Ratio is at 2.29. In the meantime, Its Debt-to-Equity ratio is 0.43 whereas as Long-Term Debt/Eq ratio is at 0.42.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on February 14, 2024, Reiterated its Buy rating but revised its target price to $300 from $305 previously.
On February 14, 2024, Wells Fargo Downgraded its rating to Equal Weight which previously was Overweight and also lowered its target price recommendation from $315 to $240.
UBS Downgraded its Buy to Neutral on January 24, 2024, whereas the target price for the stock was revised from $311 to $276.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 02 ’24 when Singhal Priya sold 93 shares for $213.09 per share. The transaction valued at 19,817 led to the insider holds 4,886 shares of the business.
Singhal Priya sold 262 shares of BIIB for $57,962 on Feb 22 ’24. The Head of Development now owns 4,886 shares after completing the transaction at $221.23 per share. On Feb 16 ’24, another insider, Singhal Priya, who serves as the Head of Development of the company, sold 108 shares for $221.49 each. As a result, the insider received 23,921 and left with 5,148 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BIIB now has a Market Capitalization of 29369829376 and an Enterprise Value of 33968869376. As of this moment, Biogen’s Price-to-Earnings (P/E) ratio for their current fiscal year is 25.39, and their Forward P/E ratio for the next fiscal year is 11.68. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 7.05. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.16 while its Price-to-Book (P/B) ratio in mrq is 1.85. Its current Enterprise Value per Revenue stands at 3.512 whereas that against EBITDA is 12.447.
Stock Price History:
The Beta on a monthly basis for BIIB is -0.04, which has changed by -0.23189735 over the last 52 weeks, in comparison to a change of 0.24841464 over the same period for the S&P500. Over the past 52 weeks, BIIB has reached a high of $272.23, while it has fallen to a 52-week low of $189.44. The 50-Day Moving Average of the stock is -9.06%, while the 200-Day Moving Average is calculated to be -11.41%.
Shares Statistics:
The stock has traded on average 1.06M shares per day over the past 3-months and 1124220 shares per day over the last 10 days, according to various share statistics. A total of 144.90M shares are outstanding, with a floating share count of 144.54M. Insiders hold about 0.77% of the company’s shares, while institutions hold 89.29% stake in the company. Shares short for BIIB as of 1722384000 were 2734637 with a Short Ratio of 2.57, compared to 1719532800 on 2742123. Therefore, it implies a Short% of Shares Outstanding of 2734637 and a Short% of Float of 2.12.
